The novel coronavirus 2019 (COVID-19) has affected nearly every country worldwide. Reports note increased thromboembolic events among hospitalized patients and anecdotal observations of improved outcomes with systemic anticoagulation (AC). However the specific role of AC in disease management remains unclear. We assessed association between administration of in-hospital AC and survival in a large cohort of hospitalized patients with COVID-19. This work was approved by the Institutional Review Board at the Icahn School of Medicine at Mount Sinai (#20-03271)
You may also like
Video: The Determinants of Cardiac Output
This 22-minute video presentation explains fundamental but often misunderstood concepts about the determinants of cardiac output, using Dr. Anderson's hydraulic model of the cardiovascular system. It is a useful summary and overview of the concepts presented in greater detail in the online text.
A Thrombus Susceptibility Comparison of Two Pulsatile Penn State 50 cc Left Ventricular Assist Device Designs
Results of this study indicate that the V-2 device had an overall lower propensity for thrombus formation in the current region of interest.